Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma

Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype

(2014) Patrícia Henriques Domingues et al.   NEURO-ONCOLOGY

Simpson grade: an opportunity to reassess the need for complete resection of meningiomas

(2013) James Barry Heald et al.   ACTA NEUROCHIRURGICA

Phosphohistone-H3 and Ki-67 immunostaining in cutaneous pilar leiomyoma and leiomyosarcoma (atypical intradermal smooth muscle neoplasm)

(2013) Munir H Idriss et al.   JOURNAL OF CUTANEOUS PATHOLOGY

The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection

(2013) Douglas A. Hardesty et al.   JOURNAL OF NEUROSURGERY

An International Ki67 Reproducibility Study

(2013) Mei-Yin C. Polley et al.   JNCI-Journal of the National Cancer Institute

Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma

(2013) Michael T Tetzlaff et al.   MODERN PATHOLOGY

Does Mitosis-Specific Marker Phosphohistone H3 Help the Grading of Upper Tract Urothelial Carcinomas in Cell Blocks?

(2012) Charalambos C. Solomides et al.   ACTA CYTOLOGICA

Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas

(2012) Soichi Oya et al.   JOURNAL OF NEUROSURGERY

Impaired survival and long-term neurological problems in benign meningioma

(2012) Hanna van Alkemade et al.   NEURO-ONCOLOGY

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

(2012) Zsuzsanna Varga et al.   PLoS One

Level of phosphohistone H3 among various types of human cancers

(2012) Amy Sun et al.   BMJ Open

Using the Mitosis-Specific Marker Anti–Phosphohistone H3 to Assess Mitosis in Pulmonary Neuroendocrine Carcinomas

(2011) Koji Tsuta et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

pHH3 Immunostaining Improves Interobserver Agreement of Mitotic Index in Thin Melanomas

(2011) Tobias T. Schimming et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study

(2011) Andreas H Habberstad et al.   Diagnostic Pathology

A Correlation for the 21st Century

(2011) T. Speed   SCIENCE

Detecting Novel Associations in Large Data Sets

(2011) D. N. Reshef et al.   SCIENCE

Frequent Mitotic Activity in Banal Melanocytic Nevi Uncovered by Immunohistochemical Analysis

(2010) Katharina Glatz et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Use of Anti-phosphohistone H3 Immunohistochemistry to Determine Mitotic Rate in Thin Melanoma

(2010) David J Casper et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

The significance of Ki-67/MIB-1 labeling index in human meningiomas: A literature study

(2010) Ellen Abry et al.   PATHOLOGY RESEARCH AND PRACTICE

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases

(2009) Shintaro Fukushima et al.   Brain Tumor Pathology

Mitosis-specific Marker Phospho-histone H3 in the Assessment of Mitotic Index in Uterine Smooth Muscle Tumors: A Pilot Study

(2009) Emanuela Veras et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION

(2009) Manish K. Aghi et al.   NEUROSURGERY